It is understood that from the beginning of last year, infusion product upgrades accelerated, plastic bottles and non-PVC soft bag infusion began to completely replace the glass bottle infusion, Jinjian Pharmaceutical is still likely to continue to expand the plastic bottled infusion production capacity.
The data shows that in 2007 China's large infusion market capacity exceeded 6 billion bottles, and this product replacement will inevitably cause a new round of industry competition.
Glass bottle "abdicate"?
After a fierce price war in previous years, the big infusion industry ushered in a turning point in 2005. July 1, 2005, with the basic replacement of butyl rubber infusion, the large infusion industry began to raise prices, and then entered a relatively stable stage.
However, since 2006, the calm infusion industry has begun to brewing a new round of changes. This change is caused by the accelerated replacement of large infusion product packaging. Before the entire infusion market dominated by glass bottles infusion, its market share of more than 70%; plastic bottles and non-PVC soft bag infusion is a high-end product market, the share is about 30%. However, since 2006, the rate of infusion of plastic bottles and non-PVC soft bags to replace glass bottles has accelerated significantly, especially since last year.
Previously, large infusion industry experts generally believed that from the experience of foreign markets, the gradual replacement of glass bottles with flexible packaging is a trend. Glass bottle infusion has the disadvantages of transportation difficulties, inconvenient use, and non-environmental protection. However, experts said that they did not expect the replacement conference to come so fast. There may be two reasons for this. On the one hand, as the country's increase in medical investment, the increase in residents' drug use levels led to the conversion of soft packaging infusions from the original high-end products to common products; On the one hand, as the cost of plastic bottle infusion production decreases year by year, the gap between the retail price and the glass bottle is narrowing. Once the price drops to a certain range, it will accelerate the speed of market penetration.
A local Hunan infusion distributor revealed to reporters that with the acceleration of industrialization in recent years and the continuous maturation of the production process, the cost of large-scale infusion of soft packaging has been declining year by year. The current retail price of 100ML plastic bottle infusion has entered 4 The interval between the yuan and the glass bottle infusion retail price is less than 2 yuan.
The source believes that with the implementation of the new rural cooperative medical system in the past two years, the increase in the country's medical subsidies for rural residents has increased the level of drug use in the third terminal. Since last year, the sales volume of flexible packaging infusion in the third terminal market has grown rapidly.
The rise of the central plate
Some analysts pointed out that in the glass bottle infusion era, the country more than 200 large infusion companies after several years of price warfare baptism, the market concentration gradually increased, the entire market structure is also relatively clear, in addition to Cologne and Shuanghe two major national giants In addition, the remaining production capacity is mainly concentrated in northern regions such as Shandong and Hebei.
However, the capacity of flexible packaging infusion is not the same. According to statistics, at present, about 26 factories in China have introduced various kinds of plastic flexible packaging infusion production lines, of which 13 are soft bag infusion production lines and 13 plastic bottle infusion production lines are mainly distributed in Beijing, Tianjin, Shanghai, Hunan and other provinces and cities. Glass bottle infusion production capacity distribution is very different, coupled with long investment cycle of infusion production line, the amount of investment is high, so once the product is speeded up, many glass bottle production companies do not advance layout, it is difficult to achieve a short-term transformation.
Once the product upgrade is speeded up, the current pattern of large infusion markets will inevitably be reshuffled. A group of enterprises with large plastic bottle production capacity, fast transportation, and guaranteed quality will ensure that the market supply companies will rise rapidly.
In June 2006, Shanghai Huayuan Changfu teamed up with Malaysia’s largest pharmaceutical business company—Tama Shengshi established Wuxi Huayuan Changfufama Pharmaceutical Co., Ltd., and the new company launched a flexible packaging infusion production line with a capacity of 20 million to 30 million bottles. Since then, several companies have launched flexible packaging infusion production lines.
According to a market person in Jinjian Pharmaceuticals, Jinjian Pharmaceuticals is a new member of the industry. In 2000 Jinjian Rice invested its hopes in plastic bottled infusions when investing in the pharmaceutical industry. It should be said that such decisions are highly forward-looking. The company launched two plastic bottle infusion production lines in two phases in 2002 and 2004 in the period when glass bottles dominated the market. In 2006, it launched four production lines and successively invested up to 200 million yuan. "Our goal is to become the overlord of the infusion market in the central region in this round of market adjustments. The market mainly covers provinces such as Hunan, Guangdong, Guangxi, Jiangxi, Fujian and Hubei," he said.
Analysis of market participants, the next large infusion market pattern is likely to re-arrange around the production capacity of plastic bottles and flexible packaging infusion, in addition to Cologne and Shuanghe through the country's production base to dominate the country, the Jinjian Pharmaceutical and a small number of large-scale investment Soft packaging infusion companies may become regional overlords, plastic bottled infusion because of low logistics costs, not easily damaged and other advantages, the large infusion products to the market radiation radius from the glass bottle of 600 km into a nationwide region without restrictions.
Layout core market
According to the reporter's understanding, at present, it is a critical period for the replacement of large infusion products. Plastic bottles and non-PVC soft bag infusions will appear many gaps in the process of replacing glass bottles for infusion, becoming a competition for plastic bottles and non-PVC soft bag infusion companies. Focus, at this stage, plastic bottled infusion will be the main replacement product.
It is reported that the Guangdong market is an important area for the distribution of Jinjian South China Market. Currently, Jinjian Pharmaceuticals is focusing on building a sales network in the Guangdong market.
Huang Xuefeng, chairman of Guangdong Yuefeng Pharmaceutical Co., Ltd., told reporters that the level of drugs used in the Guangdong market is relatively high, plastic bottles and non-PVC soft bag infusion to replace glass bottles infusion faster, it is estimated that in the next 3 years, plastic bottles and non- The market share of PVC soft bag infusion will change from 30% to 70%, becoming mainstream products. The Guangdong market has always been a key area for sales of large infusion products. Its market capacity exceeds 1 billion bottles, accounting for 1/10 of the national market. However, the output of Guangdong's local infusion companies is relatively small, and plastic bottles and non-PVC soft bags will be replaced during the infusion process. Produce 40% of the market space, so currently infusion companies from outside the province are stepping up the layout in the Guangdong market.
Bamboo Tv Cabinet,Modern Bamboo Tv Cabinet,Natural Bamboo Tv Cabinet,Living Room Bamboo Tv Cabinet
Sichuan Shihai Import And Export Trade Co.Ltd , https://www.zgshzm.com